Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hyper-accelerated immunotherapy with Hymenoptera venoms].

A Sabbah, J C Bonneau, M Drouet

    Allergie Et Immunologie
    |April 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Associations between foot lesions and carcass traits in young bulls reared indoors.

    Animal : an international journal of animal bioscience·2025
    Same author

    Muscle regeneration after high-dose radiation exposure: therapeutic potential of Hedgehog pathway modulation?

    International journal of radiation biology·2021
    Same author

    Gene Expression Changes in Irradiated Baboons: A Summary and Interpretation of a Decade of Findings.

    Radiation research·2021
    Same author

    Differentiating Total- or Partial-Body Irradiation in Baboons Using mRNA Expression Patterns: A Proof of Concept.

    Radiation research·2020
    Same author

    miRNA Expression Patterns Differ by Total- or Partial-Body Radiation Exposure in Baboons.

    Radiation research·2019
    Same author

    Gene therapy and cell therapy for the management of radiation damages to healthy tissues: Rationale and early results.

    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2019
    Same journal

    [The place of new antihistamines in allergy management. Apropos of desloratadine].

    Allergie et immunologie·2003
    Same journal

    [Skin tests for trophallergens and asthma].

    Allergie et immunologie·2003
    Same journal

    [Prevention of respiratory syncytial virus infection by SYNAGIS (palivizumab)].

    Allergie et immunologie·2003
    Same journal

    [Compendium of specific IgE values according to professional allergists].

    Allergie et immunologie·2003
    Same journal

    [Value of quantitative IgE measurement].

    Allergie et immunologie·2003
    Same journal

    Capillary leakage syndrome: a case report and a review.

    Allergie et immunologie·2003
    See all related articles

    Rapid immunotherapy using hymenoptera venoms can be safely administered in hours, not days. This accelerated approach, based on skin sensitivity tests, helps prevent severe allergic reactions during venom immunotherapy.

    Area of Science:

    • Allergy and Immunology
    • Pharmacology

    Context:

    • Hymenoptera venom immunotherapy (VIT) is a crucial treatment for allergic individuals.
    • Traditional VIT protocols require prolonged exposure over days or weeks.
    • The risk of systemic reactions and anaphylaxis during desensitization necessitates careful administration.

    Purpose:

    • To introduce and evaluate hyper-accelerated immunotherapy protocols for hymenoptera venom allergies.
    • To establish clear indications for different accelerated treatment durations (3.5 hours, 6 hours, 3 days) based on patient sensitivity.
    • To minimize the risk of adverse events during venom immunotherapy.

    Summary:

    • Hyper-accelerated immunotherapy protocols for hymenoptera venoms can be completed in 3.5 to 6 hours.
    • Treatment duration is determined by skin sensitivity test results to specific venoms (wasp, bee, hornet).

    Related Experiment Videos

  • The 3.5-hour protocol is for mild wasp venom sensitivity, the 6-hour protocol for mild bee/hornet or strong wasp sensitivity, and a 3-day protocol for strong bee/hornet sensitivity.
  • Impact:

    • Enables faster desensitization for patients with hymenoptera venom allergies.
    • Potentially reduces patient burden and improves treatment adherence.
    • Aims to maintain treatment efficacy while significantly reducing the risk of systemic reactions and anaphylaxis.